Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1992 Nov;216(5):560–564. doi: 10.1097/00000658-199211000-00006

Immunohistochemical characteristics of human milk-fat globule antibodies in predicting chest wall and distant metastasis after mastectomy for localized cancer of the breast.

E E Sterns 1, W A Fletcher 1, B Zee 1
PMCID: PMC1242673  PMID: 1444647

Abstract

Because postoperative radiation reduces chest wall metastasis after mastectomy, it is important to identify patients in whom it might develop. Pathologic and immunohistochemical features in 59 patients with chest wall metastasis were compared with characteristics in disease-free patients and patients with systemic metastases without chest wall metastasis. Immunohistochemical studies with human milk-fat globule (HMFG)-2 were not predictive, but a membrane reaction with HMFG-1 was associated with fewer systemic metastases and tumors, in which most of the cells reacted with the antibody had significantly decreased likelihood of chest wall metastasis. Antigenic concordance between the primary breast cancer and the chest wall metastasis was demonstrated. Neither tumor size nor axillary node metastasis predicted development of chest wall metastasis, but systemic metastases were less common when fewer than four nodes were involved, the primary tumor was well differentiated, and estrogen receptors were positive.

Full text

PDF
560

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bedwinek J. M., Lee J., Fineberg B., Ocwieza M. Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer. 1981 May 1;47(9):2232–2235. doi: 10.1002/1097-0142(19810501)47:9<2232::aid-cncr2820470921>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  3. Davis B. W., Gelber R. D., Goldhirsch A., Hartmann W. H., Locher G. W., Reed R., Golouh R., Säve-Söderbergh J., Holloway L., Russell I. Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer. 1986 Dec 15;58(12):2662–2670. doi: 10.1002/1097-0142(19861215)58:12<2662::aid-cncr2820581219>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  4. Gilliland M. D., Barton R. M., Copeland E. M., 3rd The implications of local recurrence of breast cancer as the first site of therapeutic failure. Ann Surg. 1983 Mar;197(3):284–287. doi: 10.1097/00000658-198303000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hsieh F. Y. Sample size tables for logistic regression. Stat Med. 1989 Jul;8(7):795–802. doi: 10.1002/sim.4780080704. [DOI] [PubMed] [Google Scholar]
  6. Magno L., Bignardi M., Micheletti E., Bardelli D., Plebani F. Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer. Cancer. 1987 Jul 15;60(2):240–244. doi: 10.1002/1097-0142(19870715)60:2<240::aid-cncr2820600221>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  7. Ottesen G., Andersen J. A., Blichert-Toft M., Axelsson C. Frequency and types of chest wall recurrences among node negative breast cancer patients. Acta Oncol. 1988;27(6A):601–604. doi: 10.3109/02841868809091758. [DOI] [PubMed] [Google Scholar]
  8. Overgaard M., Christensen J. J., Johansen H., Nybo-Rasmussen A., Brincker H., van der Kooy P., Frederiksen P. L., Laursen F., Panduro J., Sørensen N. E. Postmastectomy irradiation in high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group trials. Acta Oncol. 1988;27(6A):707–714. doi: 10.3109/02841868809091773. [DOI] [PubMed] [Google Scholar]
  9. Patanaphan V., Salazar O. M., Poussin-Rosillo H. Prognosticators in recurrent breast cancer. A 15-year experience with irradiation. Cancer. 1984 Jul 15;54(2):228–234. doi: 10.1002/1097-0142(19840715)54:2<228::aid-cncr2820540209>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  10. Probstfeld M. R., O'Connell T. X. Treatment of locally recurrent breast carcinoma. Arch Surg. 1989 Oct;124(10):1127–1130. doi: 10.1001/archsurg.1989.01410100025005. [DOI] [PubMed] [Google Scholar]
  11. Shi Z. R., Itzkowitz S. H., Kim Y. S. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem. 1988 Mar;36(3):317–322. doi: 10.1177/36.3.3278057. [DOI] [PubMed] [Google Scholar]
  12. Stadler B., Kogelnik H. D. Local control and outcome of patients irradiated for isolated chest wall recurrences of breast cancer. Radiother Oncol. 1987 Feb;8(2):105–111. doi: 10.1016/s0167-8140(87)80163-9. [DOI] [PubMed] [Google Scholar]
  13. Sterns E. E., Cochran A. J. Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast. Surg Gynecol Obstet. 1989 Jul;169(1):81–98. [PubMed] [Google Scholar]
  14. Sterns E. E., Fletcher W. A. Bilateral cancer of the breast: a review of clinical, histologic, and immunohistologic characteristics. Surgery. 1991 Oct;110(4):617–622. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES